Publications by authors named "Sae Ishimaru"

Claim this Profile
G
Global regulatory variability in small-molecule inhibitor approvals: Differences in timelines, dosing, and pediatric indications across FDA, EMA, and PMDA.
Antía Gómez-Fernández, Alba Rubio-San-Simón, Sae Ishimaru, Jen-Hao Wu, C Michel Zwaan

Clin Transl Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platform trial for off-label oncology drugs using comprehensive genomic profiling under the universal public healthcare system: the BELIEVE trial.
Sae Ishimaru, Tatsunori Shimoi, Kuniko Sunami, Miho Nakajima, Yayoi Ando

Int J Clin Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PedAL/EuPAL Project: A Global Initiative to Address the Unmet Medical Needs of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia.
Valeria Ceolin, Sae Ishimaru, Seth E Karol, Francisco Bautista, Bianca Frederika Goemans

Cancers (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of pathogenic variants in cancer-predisposing genes in second cancer after childhood solid cancers.
Masanori Yoshida, Kazuhiko Nakabayashi, Wentao Yang, Aiko Sato-Otsubo, Shin-Ichi Tsujimoto, Sae Ishimaru

Cancer Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of KIR-ligand mismatch on pediatric T-cell acute lymphoblastic leukemia in unrelated cord blood transplantation.
Yuta Kawahara, Sae Ishimaru, Junji Tanaka, Shinichi Kako, Masahiro Hirayama

Transplant Cell Ther· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors of children and adolescents with T-cell acute lymphoblastic leukemia after allogeneic transplantation.
Hisashi Ishida, Motohiro Kato, Yuta Kawahara, Sae Ishimaru, Yuho Najima

Hematol Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of the revised International Prognostic Scoring System five-group cytogenetic abnormality classification for the outcome prediction of hematopoietic stem cell transplantation in pediatric myelodysplastic syndrome.
Shohei Yamamoto, Motohiro Kato, Kenichiro Watanabe, Sae Ishimaru, Daisuke Hasegawa

Bone Marrow Transplant· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NUDT15 variants confer high incidence of second malignancies in children with acute lymphoblastic leukemia.
Masanori Yoshida, Kazuhiko Nakabayashi, Wentao Yang, Aiko Sato-Otsubo, Shin-Ichi Tsujimoto, Sae Ishimaru

Blood Adv· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic stem cell transplantation for infants with high-risk KMT2A gene-rearranged acute lymphoblastic leukemia.
Takayuki Takachi, Tomoyuki Watanabe, Takako Miyamura, Akiko Moriya Saito, Takao Deguchi, Sae Ishimaru

Blood Adv· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Successful treatment of very severe late-onset sinusoidal obstruction syndrome with recombinant human soluble thrombomodulin, steroids, and control of intra-abdominal pressure].
Tsuneaki Hirakawa, Takashi Tanaka, Junya Matsumi, Wataru Takeda, Sung-Won Kim, Sae Ishimaru

Rinsho Ketsueki· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nationwide study of pediatric B-cell precursor acute lymphoblastic leukemia with chromosome 8q24/MYC rearrangement in Japan.
Kimiyoshi Sakaguchi, Toshihiko Imamura, Sae Ishimaru, Chihaya Imai, Hidemi Shimonodan

Pediatr Blood Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nationwide survey of pediatric hypodiploid acute lymphoblastic leukemia in Japan.
Sae Ishimaru, Yasuhiro Okamoto, Chihaya Imai, Hirotoshi Sakaguchi, Tomohiko Taki

Pediatr Int· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of aprepitant and fosaprepitant in pediatric patients.
Yoshimasa Saito, Tadashi Kumamoto, Takamichi Arima, Nami Shirakawa, Sae Ishimaru

Pediatr Int· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of recurrent histiocytic sarcoma with MAP2K1 pathogenic variant treated with the MEK inhibitor trametinib.
Tadashi Kumamoto, Yuki Aoki, Tomoko Sonoda, Miho Yamanishi, Ayumu Arakawa, Sae Ishimaru

Int J Hematol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with posttraumatic growth among parents of children with cancer.
Nao Nakayama, Naoko Mori, Sae Ishimaru, Wataru Ohyama, Yuki Yuza

Psychooncology· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of UGT2B17 deletion polymorphism on prognosis in pediatric cancer.
Sae Ishimaru, Yuki Yuza, Takashi Kaneko, Mitsuyoshi Urashima

Pediatr Int· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First report of an Asian family with hemoglobin Evans [α2 62 (E11) Val → Met].
Sae Ishimaru, Yuya Saito, Yuichi Yokokawa, Yuki Yuza, Takashi Kaneko

Pediatr Int· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis